Treatment of proximal deep-vein thrombosis with the oral direct factor Xa inhibitor rivaroxaban (bay 59–7939): The odixa-dvt (oral direct factor Xa inhibitor bay 59–7939 in patients with acute symptomatic deepvein thrombosis) study - Agnelli, G; Gallus, A; Goldhaber, SZ (Circulation, 2007)
et al.